BB Biotech AG BBAGF:Over The Counter Mkt

RT Quote | Exchange | USD
Last | 12/22/21 GMT
82.40UNCH (UNCH)
52 week range
81.36 - 97.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close82.40
  • 52 Week High97.40
  • 52 Week High Date08/02/21
  • 52 Week Low81.36
  • 52 Week Low Date11/24/21

Key Stats

  • Market Cap3,272.13M
  • Shares Out55.13M
  • 10 Day Average Volume-
  • Dividend4.14
  • Dividend Yield5.02%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close82.40
  • 52 Week High97.40
  • 52 Week High Date08/02/21
  • 52 Week Low81.36
  • 52 Week Low Date11/24/21
  • Market Cap3,272.13M
  • Shares Out55.13M
  • 10 Day Average Volume-
  • Dividend4.14
  • Dividend Yield5.02%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-18.21
  • P/E (TTM)-4.52
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/21/2022
  • Div Amount3.85
  • Split Date-
  • Split Factor-

Latest On BB Biotech AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk...
Erich Hunziker Ph.D.
Chairman of the Board
Clive Meanwell M.D., Ph.D.
Vice Chairman of the Board of Directors
Address
Schwertstrasse 6
Schaffhausen
8200
Switzerland